Home › Steatotic Liver Disease › California › San Diego
Pag-aaral pangklinika para sa Steatotic Liver Disease sa San Diego, CA
14 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Diego (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Nagre-recruitPhase 3
- 89bio Clinical Study Site, Coronado · 2 mi ang layo
- 89bio Clinical Study Site, La Jolla · 11 mi ang layo
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Nagre-recruitPhase 3
- 89bio Clinical Study Site, Coronado · 2 mi ang layo
- 89bio Clinical Study Site, La Jolla · 11 mi ang layo
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Nagre-recruitPhase 2
- Southern California Research Center, Coronado · 2 mi ang layo
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Nagre-recruitPhase 2
- University of California San Diego NAFLD Research Center, La Jolla · 11 mi ang layo
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Nagre-recruitPhase 2
- Southern California Research Center, Coronado · 2 mi ang layo
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Nagre-recruitPhase 3
- Medical Associates Research Group, San Diego
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi ang layo
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Nagre-recruitPhase 3
- Akero Clinical Study Site, Coronado · 2 mi ang layo
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Nagre-recruitPhase 3
- GSK Investigational Site, San Diego
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Nagre-recruitPhase 2
- UCSD Medical Center, La Jolla · 11 mi ang layo
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Nagre-recruitPhase 2
- GSK Investigational Site, Coronado · 2 mi ang layo
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Nagre-recruitPhase 3
- GSK Investigational Site, San Diego
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Nagre-recruitObservasyonal na pag-aaral
- University of California San Diego, La Jolla · 11 mi ang layo
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
Nagre-recruitObservasyonal na pag-aaral
- University of California San Diego, La Jolla · 11 mi ang layo
Implementing Food Referrals for Equity and Sustained Health
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- Rady Children's Hospital San Diego, San Diego
Pag-aaral para sa Steatotic Liver Disease sa ibang lungsod
- San Antonio, TX17 pag-aaral
- New York City, NY16 pag-aaral
- Miami, FL16 pag-aaral
- Austin, TX13 pag-aaral
- Houston, TX13 pag-aaral
- Richmond, VA12 pag-aaral
- Chandler, AZ10 pag-aaral
- Tucson, AZ10 pag-aaral
- Orlando, FL9 pag-aaral
- Dallas, TX9 pag-aaral
- St. Louis, MO9 pag-aaral
- Hialeah, FL9 pag-aaral
Iba pang pag-aaral sa San Diego
- Non-Small Cell Lung Cancer48 pag-aaral
- Kanser sa Suso41 pag-aaral
- Kanser (lahat ng uri)32 pag-aaral
- Kanser sa Prostate31 pag-aaral
- Metastatic Cancer30 pag-aaral
- Colorectal Cancer25 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Kanser sa Pancreas24 pag-aaral
- Kanser sa Baga23 pag-aaral
- Obesity23 pag-aaral
- Pagkabigo ng Puso23 pag-aaral
- Depression21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.